J Pearson Selected Research

J Pearson Research Topics

3	Neoplasms (Cancer) 10/2017 - 03/2001
3	Syncope (Fainting) 10/2014 - 02/2013
2	Infections 01/2022 - 02/2001
2	Alzheimer Disease (Alzheimer's Disease) 06/2001 - 12/2000
1	Neurologic Manifestations (Neurological Manifestations) 01/2022
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2017
1	Carcinogenesis 10/2017
1	Rectal Neoplasms (Rectal Cancer) 07/2017
1	Colonic Neoplasms (Colon Cancer) 07/2017
1	Cystic Fibrosis (Mucoviscidosis) 01/2017
1	Colorectal Neoplasms (Colorectal Cancer) 08/2016
1	Endometritis 06/2015
1	Hemorrhage 10/2014
1	Body Weight (Weight, Body) 07/2013
1	Multiple Myeloma 02/2013
1	Maternal Obesity 12/2012
1	Obesity 12/2012
1	Porokeratosis (Palmoplantar Porokeratosis) 07/2011
1	Cysts 11/2006
1	Prostatic Neoplasms (Prostate Cancer) 04/2006
1	Autistic Disorder (Autism) 03/2002
1	Autism Spectrum Disorder 03/2002
1	Amyloid Plaque 06/2001
1	Inflammation (Inflammations) 04/2001
1	Hypersensitivity (Allergy) 03/2001
1	Breast Neoplasms (Breast Cancer) 03/2001
1	Adenocarcinoma 03/2001
1	Bacteriuria 02/2001
1	Cognitive Dysfunction 12/2000
1	Osteoporosis 03/2000

2	Amyloid (Amyloid Fibrils)IBA 06/2001 - 12/2000
2	Amyloid beta-PeptidesIBA 06/2001 - 12/2000
2	Peptides (Polypeptides)IBA 04/2001 - 12/2000
2	Proteins (Proteins, Gene)FDA Link 03/2001 - 12/2000
1	Bile Acids and Salts (Bile Acids)IBA 10/2017
1	insulin receptor-related receptor (IRR)IBA 07/2017
1	Pharmaceutical PreparationsIBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 08/2016
1	Glucose (Dextrose)FDA LinkGeneric 06/2015
1	SolutionsIBA 06/2015
1	Thalidomide (Thalomid)FDA Link 02/2013
1	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 12/2012
1	CytochromesIBA 12/2012
1	EnzymesIBA 12/2012
1	Imiquimod (Aldara)FDA LinkGeneric 07/2011
1	IntegrinsIBA 11/2006
1	Antipsychotic Agents (Antipsychotics)IBA 03/2002
1	thioflavin TIBA 06/2001
1	Presenilin-1IBA 06/2001
1	InterleukinsIBA 04/2001
1	Interleukin-8 (Interleukin 8)IBA 04/2001
1	MannansIBA 03/2001
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2001
1	Mannose ReceptorIBA 03/2001
1	Mucin-1 (CA 15-3 Antigen)IBA 03/2001
1	aerobactinIBA 02/2001
1	Mannose (D-Mannose)IBA 02/2001
1	cytotoxic necrotizing factor type 1IBA 02/2001
1	Raloxifene Hydrochloride (Evista)FDA Link 03/2000
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 03/2000

3	Lower Body Negative Pressure 10/2014 - 02/2013
3	Therapeutics 02/2013 - 03/2000
1	Hip Replacement Arthroplasty (Total Hip Replacement) 01/2022
1	Gastrostomy 01/2017
1	Radiotherapy 04/2006
1	Immunotherapy 03/2001